![]() |
DOSAGE IN RENAL FAILURE AND RENAL REPLACEMENT THERAPY:. when administering amlodipine besylate to patients with severe hepatic impairment. L' ipotesi testata nello studio ASCOT-BPLA è: ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|